Saroja Pharma Industries India Ltd.

View in App
55.05 0.00

11 December 2023, 03:32:05 PM
Volume: 0

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sarojapharma.com
Market Cap 22.13 Cr.
Enterprise Value(EV) 34.44 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.64 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 20.87 Trailing Twelve Months Ending 2023-03
Industry PE 38.52 Trailing Twelve Months Ending 2023-03
Book Value / Share 35.32 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.56 Calculated using Price: 55.05
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.40 Cr. 4,020,486 Shares
FaceValue 10
About Saroja Pharma Industries India Ltd.
The company is engaged into the business of trading of pharma products like pharma API, Pharma Intermediary and Pharma chemicals.

Saroja Pharma Industries India Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Saroja Pharma Industries India Ltd. Performance

View details >>
1 Day
1 Week
-10.12%
1 Month
-7.17%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year

Saroja Pharma Industries India Ltd. Fundamental Ratios

View details >>
3 years 2021-03 2022-03 2023-03
Return on Equity (%) 78.14 45.95 23.28
Return on Capital Employed (%) 34.59 33.73 22.10
Return on Assets (%) 8.89 9.61 5.76

Saroja Pharma Industries India Ltd. Balance Sheet

View details >>
Particulars 4 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 4 5 15
Non Curr. Liab. 1 2 3 5
Curr. Liab. 6 10 13 14
Minority Int.
Equity & Liab. 8 16 21 34
Non Curr. Assets 0 0 5 6
Curr. Assets 8 15 16 27
Misc. Exp. not W/O
Total Assets 8 16 21 34

Saroja Pharma Industries India Ltd. Profit and Loss

View details >>
Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 37 56 50
Other Income 0 0 0
Total Income 37 56 50
Total Expenditure -35 -54 -47
PBIDT 1 2 3
Interest 0 -1 -1
Depreciation 0 0 0
Taxation 0 0 0
Exceptional Items
PAT 1 1 1
Adjusted EPS 56 4 4

Saroja Pharma Industries India Ltd. Cash Flow

View details >>
Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 -4 2
Cash Fr. Inv. 0 0 -5
Cash Fr. Finan. 1 4 3
Net Change 0 0 0
Cash & Cash Eqvt 0 0

Saroja Pharma Industries India Ltd. Shareholding Pattern

View details >>
1 Qtrs 2023-09 (%)
Promoter 73.02
Public 26.99
Depository Receipts 0.00
Promoter Holding Pledge (%) 0.00

Saroja Pharma Industries India Ltd. Announcements

View details >>

No Corporate Announcement found.

Saroja Pharma Industries India Ltd. Technical Scans

View details >>
Fri, 08 Dec 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Saroja Pharma Industries India Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.70 +0.0%
Cipla Ltd. 98,444.27 1,202.60 -1.4%
Divi's Laboratories Ltd. 97,728.28 3,668.25 -0.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,544.70 -0.1%
Mankind Pharma Ltd. 78,250.95 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. 69,508.23 2,075.00 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.70 +0.0%
Cipla Ltd. Consolidated 2023-09 28.51 1,202.60 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,668.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,075.00 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.70 +0.0%
Cipla Ltd. Consolidated 2023-09 3.97 1,202.60 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,668.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,075.00 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.70 +0.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.60 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,668.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.70 +0.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.60 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,668.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,075.00 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.70 +0.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.60 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,668.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,075.00 +1.0%

Saroja Pharma Industries India Ltd. FAQ's

What is Saroja Pharma Ind share price?
Can I buy Saroja Pharma Ind shares now?
What is the Market Cap of Saroja Pharma Ind?
What are the key metrics to analyse Saroja Pharma Ind?
What is the trend of Saroja Pharma Ind share price?